SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Fresh ESMO oncology updates are drawing attention, including early ovarian-cancer data for Lillys investigational Sofe-M combination; traders also debate the pullback and upcoming earnings, with bullish breakout hopes countered by concerns about fading momentum and resistance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 melanoma results for a personalized cancer vaccine added to Keytruda are the main focus, with the combination meeting recurrence-free and distant metastasis-free survival endpoints. Traders see the data as validation of Mercks oncology pipeline, while debating the vaccines broader potential, path to approval and commercial value against valuation concerns.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, range-bound trading, with repeated chart commentary describing consolidation. Holders see the pullback as a chance to accumulate or set up a rebound, while skeptics point to weak utility and worry about further declines.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins, analyst upgrades, and past earnings beats. Traders debate whether the decline reflects an expensive valuation, insider selling, and concerns about turning demand and production growth into profitsor an overdone pullback in a defense and drone company with long-term growth prospects.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Chinas rare-earth export restrictions and uncertain U.S.-China negotiations have renewed attention on MPs role in building a domestic mine-to-magnet supply chain. Traders remain divided: some see geopolitical and government support as a long-term tailwind, while others focus on the stocks prolonged decline and question near-term execution and demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on CVSs November 4 earnings report, with many positioning for a rebound after the stocks recent pullback and pointing to technical support. Others are wary of sellers and whether the shares can regain momentum ahead of the results.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated rates, inflation, energy costs and a possible AI-led correction, with traders debating whether recent weakness signals deeper risk or a buying opportunity. Some favor long-term index investing and dollar-cost averaging, while others expect further volatility and declines.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is drawing attention around its earnings setup, with traders citing stronger engagement tied to the viral game Steal an Egg and analyst optimism about bookings. Bullish momentum and call positioning compete with caution about earnings volatility and the stocks history of sharp post-report moves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Attention centers on reports that the administration is weighing temporary access to certain compounded peptides, which traders view as a potential growth opportunity for Hims; no approval is confirmed. Optimism about peptides and a possible short squeeze contrasts with frustration over repeated reversals and resistance near $30.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias FDA-accepted BLA for lonvo-z, granted Priority Review for hereditary angioedema, is the main catalyst, with traders focused on the March 2027 decision and the therapys Phase 3 results. Bulls see a potential path toward commercialization and validation of the gene-editing platform, while bears point to cash needs, commercialization risks and volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wind & Solar Overtake Gas Globally: ETFs Poised to Benefit

Wind and solar have just surpassed natural gas in global electricity generation, boosting the long-term outlook for renewable energy ETFs.

Wind Energy ETFs to Rally on Profit Beats and Iran War Energy Shift

Wind energy ETFs are back in focus as geopolitical tensions and AI-driven power demand are strengthening the bull case for wind energy.

The Zacks Analyst Blog Highlights ICLN, QCLN, CNRG, PBD and PBW

ICLN draws attention as energy security fears and rising oil volatility drive strong inflows into clean energy ETFs and boost sector momentum.

Clean Power in Focus Amid Energy Security Concerns: ETFs to Gain

Clean energy ETFs could be the real winner as energy security fears, oil volatility and strong fund inflows drive investor interest.

Is Invesco Global Clean Energy ETF (PBD) a Strong ETF Right Now?

Iran War Seen as Reason for Shift to Renewable Energy: ETFs in Focus 

Iran war accelerates global clean energy shift. Nations are planning to boost solar & wind to cut oil risks. ETFs like ICLN, QCLN, PBW in focus for long-term gains.

The Zacks Analyst Blog  ICLN,QCLN,CNRG, PBD and PBW 

Middle East tensions are pushing oil prices higher, fueling a surge in clean energy ETFs as investors eye long-term growth opportunities.

From Oil Disruption to Clean Energy Boom: ETFs Poised to Benefit

Energy security fears may fast-track the clean energy transition. Clean energy ETFs could be the real winner.

Is This the Right Time to Bet on Clean Energy ETFs?

Despite policy headwinds, surging AI-driven power demand and falling renewable costs are powering clean energy ETFs higher.

FuelCell Stock Jumps Despite Q2 Earnings Miss On Revenue Surge, New Restructuring Plan

Equity

FuelCell’s restructuring plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.

Invesco Exchange-Traded Fund Trust II - Invesco Global Clean Energy ETF

Neutral Sentiment

FuelCell Energy (FCEL) shares jumped as much as 29% at the opening bell on&nbsp;Friday after&nbsp;the company reported a surge in revenue&nbsp;and laid out a major restructuring plan to reduce costs and concentrate on its carbonate platform.FuelCell Energy reported a loss of $1.79 per share in the second quarter (Q2), an improvement over the same period last year and&nbsp;wider than the estimated loss of $1.38 per share, according to Koyfin data.Its revenue grew 67% year-on-year (YOY) to $37.4 million, coming in ahead of Wall Street’s estimate of $32 million. Management said the growth was driven by new product and&nbsp;service contract activity.&nbsp;Product revenue was $13 million compared with none in the prior-year period, while service agreements generated $8.1 million, helped by module replacements under a contract with United IlluminatingGeneration revenue declined to $12.1 million from $14.1 million, reflecting lower power output due to maintenance. Advanced technologies contract revenue also fell to $4.1 million from $6.9 million,&nbsp;partly due to reduced revenue from contracts with ExxonMobil affiliates and government agencies.The company announced a new restructuring initiative&nbsp;that will affect operations in the U.S., Canada, and Germany.&nbsp;FuelCell said the move is intended to reduce operating costs, prioritize carbonate platform development, and preserve competitiveness in a slower investment environment for clean energy.&nbsp;The plan includes a 22% reduction in workforce, bringing global headcount to approximately 426.This follows a November 2024 restructuring that targeted a 15% reduction in fiscal 2025 operating costs and included a 13% workforce cut along with trimmed spending on product development and overhead.CEO Jason Few said the company is prioritizing its core carbonate technology in response to demand from AI data centers and distributed power solutions. FuelCell is also scaling back commercial development of solid oxide platforms and trimming SG&amp;A expenses to improve its financial trajectory.CFO Michael Bishop&nbsp;highlighted the company’s ongoing cost discipline and pursuit of strategic financing.&nbsp;Cash and equivalents, including restricted cash and short-term investments, totaled $240 million at the end of the quarter, down from $318 million in October 2024.FuelCell ended the quarter with $1.26 billion in backlog, up 19% from a year earlier, supported by a long-term service agreement with Gyeonggi Green Energy in South Korea and a new 20-year power purchase agreement for a 7.4-MW fuel cell plant in Connecticut.<a href="https://stocktwits.com/symbol/FCEL">FuelCell’s stock</a> is down 77% over the past 12 months and 30% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-not-interested-in-call-with-elon-musk-say-reports/chkzrevRbUc">Trump ‘Not Interested’ In Call With Elon Musk, Say Reports</a>

The JFB Fuel Cell Power Plant, manufactured by FuelCell Energy, Inc., is unveiled at the headquarters (L) of the Los Angeles Department of Water and Power March 14, 2003 in Los Angeles, California. (Photo by David McNew/Getty Images)

Fuelcell Energy Inc

iShares Energy Storage & Materials ETF

Invesco Global Clean Energy ETF

Invesco WilderHill Clean Energy ETF

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$15.13
Prev Close	$15.26
Open	$15.16
Dividend Yield	N/A
50-Day Moving Average	$17.11
Beta	N/A
Avg. Volume	91,336.27
PE Ratio	N/A

52-Week High	$22.58
52-Week Low	$14.98
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

PBD Fundamentals